Abstract
Synergization of an endoplasmic reticulum-targeted iridium(III) photosensitizer with PD-L1 inhibitor for oral squamous cell carcinoma immunotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have